Gabapentin neurotoxicity in a chronic haemodialysis patient [5]

Nephrology Dialysis Transplantation

Volumn 16, Issue 10, 2001, Pages 2112-2113

  Bassilios, Nader ^a   Launay Vacher, Vincent ^b   Khoury, Noufoud ^a   Rondeau, Eric ^a   Deray, Gilbert ^b   Sraer, Jean Daniel ^a  

^a HÔPITAL TENON   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; DIAZEPAM; GABAPENTIN; LAMOTRIGINE; PLASMA PROTEIN; VALPROIC ACID;

ADULT; AREA UNDER THE CURVE; ATAXIA; CASE REPORT; CHRONIC KIDNEY FAILURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG TOLERABILITY; FATIGUE; FEMALE; GRAND MAL SEIZURE; HEMODIALYSIS PATIENT; HUMAN; LETTER; LONG TERM CARE; NEUROTOXICITY; PRIORITY JOURNAL; SOMNOLENCE; THROMBOCYTOPENIA; TONIC SEIZURE; VERTIGO; VISUAL DISORDER;

EID: 0034786540     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.10.2112     Document Type: Letter

References (7)

1. Pharmacokinetics of gabapentin in subjects with various degrees of renal function
2. Double-blind study of gabapentin in the treatment of partial seizures
3. Gabapentin treatment for brachradial pruritus
4. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial
5. Clinical pharmacokinetics of gabapentin
6. Disposition of gabapentin in anuric subjects on hemodialysis
7. A case of sustained massive gabapentin overdose without serious side effects